Ampio Pharm Story

AMPEDelisted Stock  USD 0.25  0.10  28.57%   
About 62% of Ampio Pharm's investor base is looking to short. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that many investors are alarmed at this time. Ampio Pharm's investor sentiment overview provides quick insight into current market opportunities from investing in Ampio Pharm. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Ampio Pharm.

Ampio Pharm Latest Timeline

Ampio Pharm is listed for 0.25. The company has price-to-book (P/B) ratio of 0.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ampio Pharm recorded a loss per share of 10.66. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 12th of September 2023.
Check out Ampio Pharm Hype Analysis, Ampio Pharm Correlation and Ampio Pharm Performance.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Ampio Pink Sheet

If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments